Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
Open-market buys, last 90 days
$29,501
in 3 filings
Open-market sales, last 90 days
$27,505
in 1 filing, $28K under 10b5-1 plans

Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-14 JANTZ DEREK Chief Scientific Officer Sale −9,673 $9.17 $89K 4,052,279
2021-05-14 JANTZ DEREK Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −21,514 0
2021-05-13 KANE MATTHEW R. President and CEO Option exercise +21,514 $0.04 $861 2,023,272
2021-05-13 KANE MATTHEW R. President and CEO Sale −9,675 $8.96 $87K 2,013,597
2021-05-13 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −21,514 0
2021-05-13 JANTZ DEREK Chief Scientific Officer Option exercise +21,514 $0.04 $861 4,050,111
2021-05-13 JANTZ DEREK Chief Scientific Officer Sale −9,673 $9.15 $89K 4,040,438
2021-05-13 JANTZ DEREK Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −21,514 21,514
2021-05-12 JANTZ DEREK Chief Scientific Officer Option exercise +21,514 $0.04 $861 4,038,273
2021-05-12 JANTZ DEREK Chief Scientific Officer Sale −9,676 $8.72 $84K 4,028,597
2021-05-12 JANTZ DEREK Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −21,514 43,028
2021-05-10 Sharp Shalini Director Grant or award · Stock Option (Right to Buy) +32,800 32,800
2021-05-10 Schinazi Raymond F Director Grant or award · Stock Option (Right to Buy) +32,800 32,800
2021-05-10 Germano Geno J Director Grant or award · Stock Option (Right to Buy) +32,800 32,800
2021-05-10 Buehler Kevin Director Grant or award · Stock Option (Right to Buy) +32,800 32,800
2021-05-10 KANE MATTHEW R. President and CEO Option exercise +21,514 $0.04 $861 2,011,504
2021-05-10 KANE MATTHEW R. President and CEO Sale −9,746 $8.25 $80K 2,001,758
2021-05-10 KANE MATTHEW R. President and CEO Option exercise · Employee Stock Option (Right to Buy) −21,514 21,514
2021-05-07 KANE MATTHEW R. President and CEO Option exercise +21,514 $0.04 $861 1,999,732
2021-05-07 KANE MATTHEW R. President and CEO Sale −9,742 $8.57 $83K 1,989,990

Page 20 of 23 · 456 trades